ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $224,000 | +3633.3% | 18,005 | +3814.1% | 0.02% | +2300.0% |
| Q3 2016 | $6,000 | -68.4% | 460 | -84.2% | 0.00% | -66.7% |
| Q1 2016 | $19,000 | -87.0% | 2,916 | -88.3% | 0.00% | -78.6% |
| Q3 2015 | $146,000 | +35.2% | 25,017 | +90.9% | 0.01% | +40.0% |
| Q2 2015 | $108,000 | -73.3% | 13,104 | -73.3% | 0.01% | -80.0% |
| Q1 2015 | $405,000 | +13400.0% | 49,148 | +9729.6% | 0.05% | – |
| Q4 2014 | $3,000 | – | 500 | – | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $17,000 | -85.3% | 2,153 | -87.3% | 0.00% | -89.5% |
| Q4 2013 | $116,000 | – | 17,004 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |